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G protein–coupled receptors (GPCRs), encoded by about 5% of human genes, comprise the largest family of integral
membrane proteins and act as cell surface receptors responsible for the transduction of endogenous signal into a
cellular response. Although tertiary structural information is crucial for function annotation and drug design, there are
few experimentally determined GPCR structures. To address this issue, we employ the recently developed threading
assembly refinement (TASSER) method to generate structure predictions for all 907 putative GPCRs in the human
genome. Unlike traditional homology modeling approaches, TASSER modeling does not require solved homologous
template structures; moreover, it often refines the structures closer to native. These features are essential for the
comprehensive modeling of all human GPCRs when close homologous templates are absent. Based on a benchmarked
confidence score, approximately 820 predicted models should have the correct folds. The majority of GPCR models
share the characteristic seven-transmembrane helix topology, but 45 ORFs are predicted to have different structures.
This is due to GPCR fragments that are predominantly from extracellular or intracellular domains as well as database
annotation errors. Our preliminary validation includes the automated modeling of bovine rhodopsin, the only solved
GPCR in the Protein Data Bank. With homologous templates excluded, the final model built by TASSER has a global Ca
root-mean-squared deviation from native of 4.6 A ˚, with a root-mean-squared deviation in the transmembrane helix
region of 2.1 A ˚. Models of several representative GPCRs are compared with mutagenesis and affinity labeling data, and
consistent agreement is demonstrated. Structure clustering of the predicted models shows that GPCRs with similar
structures tend to belong to a similar functional class even when their sequences are diverse. These results
demonstrate the usefulness and robustness of the in silico models for GPCR functional analysis. All predicted GPCR
models are freely available for noncommercial users on our Web site (http://www.bioinformatics.buffalo.edu/GPCR).
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Introduction
G protein–coupled receptors (GPCRs) are integral mem-
brane proteins embedded in the cell surface that transmit
signals to cells in response to stimuli such as light, Ca
2þ,
odorants, amino acids, nucleotides, peptides, or proteins and
mediate many physiological functions through their inter-
action with heterotrimeric G proteins [1,2]. Many diseases
involve the malfunction of these receptors, making them
important drug targets. In human, the estimated number of
GPCRs is approximately 948 [3], corresponding to about 5%
of the total number of human genes [4]. However, more than
45% of all modern drugs target GPCRs; these represent
around 25% of the 100 top-selling drugs worldwide [2,5].
While knowledge of a protein’s structure furnishes im-
portant information for understanding its function and for
drug design [6], progress in solving GPCR structures has been
slow [7]. Nuclear magnetic resonance (NMR) spectroscopy
and X-ray crystallography are the two major techniques used
to determine protein structures. NMR spectroscopy has the
advantages that the protein does not need to be crystallized
and dynamical information can be extracted. However, high
concentrations of dissolved proteins are needed; and as yet
no complete GPCR structure has been solved by the method.
X-ray crystallography can provide very precise atomic
information for globular proteins, but GPCRs are extremely
difﬁcult to crystallize. In fact, only a single GPCR, bovine
rhodopsin (RH) from the rod outer segment membrane, has
been solved [8]. It is unlikely that a signiﬁcant number of
high-resolution GPCR structures will be experimentally
solved in the very near future. This situation limits the use
of structure-based approaches for drug design and restricts
research into the mechanisms that control ligand binding to
GPCRs, activation and regulation of GPCRs, and signal
transduction mediated by GPCRs [9].
Fortunately, as demonstrated by the recent CASP experi-
ments [10], computer-based methods for deducing the three-
dimensional structure of a protein from its amino acid
sequence have been increasingly successful. Among the three
types of structure prediction algorithms—homology model-
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and ab initio folding [15–17]—CM, which builds models by
aligning the target sequence to an evolutionarily related
template structure, provides the most accurate models.
However, its success is largely dictated by the evolutionary
relationship between target and template proteins. For
example, for proteins with greater than 50% sequence
identity to their templates, CM models tend to be quite close
to the native structure, with a 1-A ˚ root-mean-squared-
deviation (RMSD) from native for their backbone atoms,
comparable to low-resolution X-ray and NMR experiments
[12,18]. When the sequence identity drops below 30%, termed
the ‘‘twilight zone,’’ CM model accuracy sharply decreases
because of the lack of a signiﬁcant structure match and
substantial alignment errors. Here, the models provided by
CM are often closer to the template on which the model is
based rather than the native structure of the sequence of
interest. This has been a signiﬁcant unsolved problem [19].
Among all registered human GPCRs, there are only four
sequences that have a sequence identity to bovine RH greater
than 30%. Ninety-nine percent of human GPCRs, with an
average sequence identity to bovine RH of 19.5%, lie outside
the traditional comparative modeling regimen [9].
Recently [14,17,20,21], we developed the threading assem-
bly reﬁnement (TASSER) methodology, which combines
threading and ab initio algorithms to span the homologous
to nonhomologous regimens. In a large-scale, comprehensive
benchmark test of 2,234 representative proteins from the
Protein Data Bank (PDB) [22], after excluding templates
having greater than 30% sequence identity to the target, two
thirds of single domain proteins can be folded to models with
aC a RMSD to native of less than 6.5 A ˚ [20,21]. As a signiﬁcant
advance over traditional homology modeling, many models
(including membrane proteins) are improved with respect to
their threading templates (858 of 2,234 targets have an RMSD
improvement of greater than 1.5 A ˚ ).
In the absence of additional GPCR crystal structures,
computer-based modeling may provide the best alternative to
obtaining structural information [23–28]. In this work, we
exploit TASSER to predict tertiary structures for all 907
GPCR sequences in the human genome that are less than 500
amino acids in length. Only the sequence of the given GPCR
is passed to TASSER and no other extrinsic knowledge (e.g.,
active sites and binding regions, experimental restraints, etc.)
is incorporated into our structure prediction approach.
Because the rearrangements of TM helices from RH may
occur for nonhomologous GPCRs, the ability to reﬁne
templates is the most important advantage of using TASSER
in comprehensive GPCR modeling. Also, distinct from many
other GPCR modeling methods that only attempt to model
the TM helical regions [27,29,30], TASSER generates reason-
able predictions for the loop regions. In benchmark tests [21],
for 39% of loops of four or more residues, TASSER models
have a global RMSD less than 3 A ˚ from native. In contrast,
using the widely used homology modeling tool, MODELLER
[11,12], the percentage of loops with this accuracy is 12% [20].
If one considers only the accuracy of the loop conformation
itself (and neglects its orientation relative to the remainder of
the protein), then 89% of the TASSER-generated loops have a
local RMSD of less than 3 A ˚ , and the average RMSD for loops
up to 50 residues is below 4 A ˚ . This is especially important in
GPCR modeling as the extracellular loops are often critical in
determining ligand speciﬁcity [31–33]. Therefore, full-length
TASSER models offer substantial advantages over traditional
comparative modeling methods and are likely to be of greater
aid in understanding the ligand and signaling interactions of
GPCRs.
Results
Application of TASSER to Membrane Proteins
Two forms of TASSER were developed for this study that
slightly differ from our previously published work
[14,17,20,21]. The ﬁrst form of TASSER was extended to
explicitly model TM proteins by including a ‘‘hydrophilic
inside’’ potential for predicted TM regions as described in
Materials and Methods. Modeling bovine RH with this form of
TASSER demonstrates the effectiveness of this approach. On
excluding homologous structures whose sequence identity
greater than 30%, PROSPECTOR_3 identiﬁed three tem-
plates, 1pv6B (lactose permease), 1b3uA (protein phosphatase
2A), and 1a8hA (methionyl-tRNA synthetase), with Z-scores of
8.1, 8.7, and 5.3, respectively; bovine RH is therefore assigned
as a medium/hard target. After the TASSER simulation, 76%
of the structures from the 14 lowest temperature replicas are
found inside a cluster with an RMSD cutoff of 8 A ˚ . The
average RMSD of these structures to the cluster centroid is
4.2 A ˚ , which gives a C-score of 0.45. Of targets with this score,
82% are foldable according to the PDB benchmark [20]. In
Figure 1, we show the comparison of both threading
templates and the model of highest structure density with
respect to the crystal structure. An RMSD of 4.6 A ˚ from
native for the ﬁnal model is obtained if we superimpose all
338 Ca atoms (ten residues are absent in the crystal structure).
The major modeling errors are in the N- and C-termini and
the C3 loop. If we excise the tails and superimpose the model
onto the core region (residues 32 to 323) of the native
structure, the RMSD between the model and native structure
is 3.3 A ˚ . When we consider only the TM helix region, that is,
TM1 (35 to 64), TM2 (71 to 100), TM3 (107 to 139), TM4 (151
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Synopsis
G protein–coupled receptors (GPCRs) are a large superfamily of
integral membrane proteins that transduce signals across the cell
membrane. Because of the breadth and importance of the
physiological roles undertaken by the GPCR family, many of its
members are important pharmacological targets. Although the
knowledge of a protein’s native structure can provide important
insight into understanding its function and for the design of new
drugs, the experimental determination of the three-dimensional
structure of GPCR membrane proteins has proved to be very
difficult. This is demonstrated by the fact that there is only one
solved GPCR structure (from bovine rhodopsin) deposited in the
Protein Data Bank library. In contrast, there are no human GPCR
structures in the Protein Data Bank. To address the need for the
tertiary structures of human GPCRs, using just sequence informa-
tion, the authors use a newly developed threading-assembly-
refinement method to generate models for all 907 registered GPCRs
in the human genome. About 820 GPCRs are anticipated to have
correct topology and transmembrane helix arrangement. A subset
of the resulting models is validated by comparison with muta-
genesis experimental data, and consistent agreement is demon-
strated.
Structure Modeling of Human GPCRsto 173), TM5 (200 to 225), TM6 (247 to 277), and TM7 (286 to
306), the RMSD is 2.1 A ˚ .
A second integrated form of TASSER was constructed that
incorporates a TM potential but selectively applies it without
prior knowledge as to whether a target sequence is a
membrane protein. Application of this integrated potential
to a benchmark set of 38 membrane proteins (excluding all
templates with greater than 30% identity in the aligned
region) results in 17 targets with an RMSD to native less than
6.5 A ˚ and an average improvement over the template
alignment of 4.9 A ˚ with 97% of targets showing an improve-
ment compared to the starting template (Figure 2). A detailed
list of the threading templates and ﬁnal model information
for the 38 membrane proteins is presented at Table 1. It
should also be noted that more than 60% of the structures in
the benchmark were proteins crystallized as part of large
heteroprotein complexes. Applying this to the four other
known seven-TM proteins in the PDB database, archeorho-
dopsin (1uaz), sensory rhodopsin (1jgj), halorhodopsin (1e12),
and bacteriorhodopsin (1ap9), yields ﬁnal models with
RMSDs to native of 2.66, 1.25, 2.39, and 1.86 A ˚ , respectively
(Table 1). In all cases, TASSER reﬁned the starting template
closer to native, with archeorhodopsin showing a change in
RMSD from 19.78 A ˚ for the highest scoring template to 1.22 A ˚
over the same aligned region in the ﬁnal model, sensory
rhodopsin showing an improvement in RMSD from 2.50 A ˚ to
1.18 A ˚ , halorhodopsin showing an improvement in RMSD
from 1.84 A ˚ to 1.48 A ˚ , and bacteriorhodopsin showing an
improvement in RMSD from 2.37 A ˚ to 1.49 A ˚ .
As indicated in Table 1, there is unfortunately no clear
pattern with regard to the type of proteins where TASSER
modeling will succeed, because its successes and failures are
scattered among the different types of membrane proteins
(including a- and b-proteins). In fact, there are two factors
contributing to the success of TASSER modeling. First, the
dominant factor is the correct identiﬁcation of analog
templates from the threading algorithm [14]. Reasonable
threading alignments provide a good starting point and
framework for the follow-up TASSER reﬁnement. Second,
the composite and optimized knowledge-based TASSER force
ﬁeld contributes to the reﬁnement of the models. The result
of the ﬁnal predictions is a combination of complex
threading and simulation procedures, which prohibits the
induction of a simple and explicit rule for when TASSER will
succeed. Nevertheless, most proteins with a TM helical
topology were well modeled by TASSER, a feature that is
important for GPCR modeling. This may be due to the well-
constructed sequence proﬁles from the extensive set of
helical proteins in the sequence database, because PROS-
PECTOR_3 partly relies on a proﬁle-proﬁle alignment and
the TASSER potential uses the short-range correlations
identiﬁed by sequence proﬁle matches.
One of the difﬁculties in validating GPCR models is the
paucity of experimental evidence that would provide a strong
validation or invalidation of a given model. However, by
providing a detailed benchmark of membrane proteins
including seven-TM proteins and bovine RH itself, we have
clearly demonstrated the ability of TASSER to reﬁne
membrane structures from low sequence–identity templates
to structures that are closer to the native structure in an
automated fashion. The automated nature of this approach
offers a potential advantage over many other human expert–
based methods that may introduce biases by a priori assuming
speciﬁc structural characteristics or restraints.
Sequence Clustering of Human GPCRs
Sequence analysis estimates that there are about 950
GPCRs in the human genome [3]. Combining the registered
Figure 1. Initial Templates from PROSPECTOR_3 and the Final TASSER Model of Highest Cluster Density Superposed on the Bovine RH Crystal Structure
Blue to red runs from N- to C-terminus. The numbers are the RMSD to native. Images are from RASMOL [120].
DOI: 10.1371/journal.pcbi.0020013.g001
Figure 2. Application of TASSER to Membrane Proteins
TASSER was applied to a benchmark set of 38 membrane proteins with
structures in the PDB. RMSD to native for final models of TASSER versus
RMSD to native for initial templates from PROSPECTOR_3. All points
beneath the 458 line indicate an improvement in the TASSER model over
the initial template. All template alignments with a sequence identity
greater than 30% were excluded from consideration.
DOI: 10.1371/journal.pcbi.0020013.g002
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Structure Modeling of Human GPCRsentries in the http://www.gpcr.org/7tm/htmls/entries.html and
http://www.expasy.org/cgi-bin/lists?7tmrlist.txt databases (Feb-
ruary 2004 release), we ﬁnd a total of 907 human GPCR
sequences less than 500 residues in length. To establish their
evolutionary distance, we made an all-against-all sequence
comparison and grouped them into clusters based on their
sequence identities. Four hundred forty-six GPCRs belong to
the same sequence cluster with greater than 30% sequence
identity; 384 of these are olfactory receptors, the largest
subfamily in class A GPCRs [1,2]. The second largest cluster
has 38 GPCR sequences, of which half are chemokine
receptors. Three hundred sixty-ﬁve GPCRs belong to 68
smaller clusters with two to 30 members, including the four-
member cluster homologous to bovine RH. The remaining 58
GPCRs are orphans with no partners having sequence
identity greater than 30%. If we use sequence cutoffs of
20%, 25%, 35%, and 40%, there are 664, 477, 377, and 308
members in the largest sequence cluster, respectively. These
data demonstrate the high sequence (and therefore structure)
diversity among the GPCRs. If the assumption is made that
GPCRs should all contain seven-TM regions—which may be
incorrect—better alignments should be constructed by
identifying helical regions explicitly. However, these se-
quence diversity data strongly suggest that direct comparative
modeling with the bovine RH structure alone is highly
unlikely to capture the nature of the structural differences
among GPCRs not only in the highly diverse loop regions but
within the core TM regions, too.
Threading Results
On threading the 907 GPCR sequences through our
template library, a representative protein set covering PDB
at the level of 35% sequence identity, PROSPECTOR_3 [14]
assigns 778 sequences as easy targets, with average alignment
coverage of 78%. This fraction of easy target assignment
(about 86%) is signiﬁcantly higher than in the PDB bench-
mark (about 67%) [20,21] and partly reﬂects the ability of
PROSPECTOR_3 to detect the seven-TM helix bundle fold.
Table 1. Modeling Result of the Benchmark Set of PDB Membrane Proteins
Target Class Template
a RT (A ˚)
b RM-ali(A ˚)
c RM-all(A ˚)
d C-Score
1a87_ Easy 1cii_ 46.38 40.91 40.35  0.7
1aigL Easy 1izlA 15.56 5.30 6.03 1.5
1aigM Medium 1izlA 9.82 3.79 10.29 1.1
1ap9_ Easy 1jgjA 2.37 1.49 1.86 2.1
1bccF Hard 1ps6A 16.30 13.12 13.37  1.1
1bccH Easy 1ga3A 9.55 7.46 8.68 1.0
1bh3_ Medium 2por_ 9.28 4.87 4.97 1.2
1bl8A Easy 2a79B 4.14 3.52 3.62 2.6
1bxwA Hard 1p4tA 16.18 4.50 4.61 0.2
1e12A Easy 1jgjA 1.84 1.48 2.38 2.1
1ezvH Hard 1zpyA 17.34 2.32 2.29 0.9
1fftC Easy 1occC 3.25 2.83 2.83 3.5
1fqyA Easy 1fx8A 4.41 3.04 3.09 1.7
1fx8A Easy 1fqyA 3.84 3.17 4.08 2.2
1gu8A Easy 1e12A 3.90 1.09 7.17 2.1
1i78A Hard 1k24A 28.05 21.37 25.04  3.5
1jb0C Medium 1clf_ 3.53 3.31 8.43 1.0
1jb0J Easy 1ug2A 13.61 4.88 4.96 1.2
1k24A Hard 1i78A 26.68 23.52 23.15  1.8
1kqfC Hard 1cd5A 21.05 17.65 19.56  1.8
1kzuA Hard 1ahl_ 14.19 4.43 5.36 0.4
1kzuB Hard 1akhA 11.81 1.56 2.87 0.7
1lghB Easy 1ocp_ 13.75 12.67 13.51  1.2
1lkfA Easy 7ahlA 17.41 17.04 16.89  3.2
1occC Easy 1fftC 3.06 2.90 17.41  0.8
1occE Hard 1ijxA 13.70 9.09 10.38  0.9
1occH Hard 1b0yA 10.90 2.66 8.16 0.2
1occJ Hard 1tig_ 15.78 14.07 14.60  0.8
1occL Hard 1nz9A 10.50 9.65 13.07  0.1
1occM Hard 1cjgA 13.72 3.61 3.60 0.3
1orqC Easy 2a79B 20.05 18.60 18.62  1.5
1qcrK Hard 1b0xA 12.83 4.68 5.05 0.1
1qd5A Hard 1x8mA 27.54 11.22 11.28  1.7
1qj8A Easy 1p4tA 5.60 3.67 3.87 2.2
1qlaC Hard 1ut9A 25.75 21.38 23.02  1.6
1qleD Hard 1t06A 16.08 3.06 4.044 0.3
1uazA Medium 1syyA 19.78 1.22 2.659 1.0
7ahlA Easy 1lkfA 16.03 16.92 19.55  3.1
aThe PDB ID of the best template with the lowest RMSD to native. All templates with sequence identity to the target greater than 30% were excluded.
bRMSD of the best template.
cRMSD of the TASSER models calculated in the threading aligned region.
dRMSD of the TASSER models calculated for the whole chain.
DOI: 10.1371/journal.pcbi.0020013.t001
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Structure Modeling of Human GPCRsOne hundred twenty-nine sequences are assigned as medium/
hard targets with average alignment coverage of 67%.
The average sequence identities between the target and
template are 17.8% and 15.5% for the easy and medium/hard
targets, respectively. Despite these low sequence identities,
there is some correlation between easy/medium/hard assign-
ments and the size of sequence clusters that partially reﬂects
the sensitivity of the sequence proﬁle term in PROSPEC-
TOR_3. Among the 48 sequence clusters with three or more
members, all members in 40 of the clusters are easy targets.
The 129 medium/hard targets are populated in a few
sequence clusters: 84 of 129 of the medium/hard targets are
olfactory receptors in sequence cluster I, and 17 of 129 are
orphan GPCRs.
For most easy targets (652/778), PROSPECTOR_3 hits at
least one of four seven-TM proteins (Sensory Rhodopsin,
Halorhodopsin, Bacteriorhodopsin, or Bovine Rhodopsin) as
templates. Although further reﬁnement of the core region
and the ab initio prediction of the loop conformations are
needed, these alignments provide a reasonable initial
conformation for TASSER. In fact, even for proteins that
do not hit these four templates, due to TASSER reﬁnement,
many are predicted to have the TM helix topology through a
fully automated procedure. As shown below, there are 862
cases where the GPCR model has a typical TM helix topology
but only 744 targets have these four TM helical proteins as
starting templates.
Confidence Score of Predicted Models
In Figure 3, the distribution of C-score, deﬁned in Equation
1, for all 907 GPCRs is shown along with the corresponding C-
score histogram of the PDB benchmark proteins [20]. Since
the quality of threading templates is better for the GPCR
proteins (reﬂected by the larger fraction of Easy targets and
higher alignment coverage), many more GPCR models are
populated at high C-scores.
In the PDB benchmark [20,21], for both globular and
membrane proteins, there is a strong correlation between the
C-score and the success rate of TASSER. For the 2,234
benchmark proteins ranging in size from 41 to 300 residues,
the correlation coefﬁcient between C-score and RMSD of the
ﬁrst model (corresponding to the most populated cluster) to
native is 0.73. Of 38 membrane proteins in the benchmark,
the correlation coefﬁcient is 0.74, indicating that the TASSER
conﬁdence scoring system is directly applicable to TM
proteins. The data in Figure 3 therefore imply that 819 of
our GPCR models should have the correct topology. That is,
for about 90% of the cases, at least one model in the top ﬁve
predictions should have a core-region with an RMSD below
6.5 A ˚ . There are 782, 749, and 698 cases with C-scores above
0.5, 1.0, and 1.5, respectively; in the benchmark, these C-
scores correspond to a TASSER success rate of 94%, 97%,
and 98%, respectively. Here, we note that a low RMSD just
indicates the correctness of the overall topology of the helical
arrangements. But the details of the loop regions and
especially the ligand-binding sites may still be inaccurate.
Further reﬁnement at an atomic level as well as including the
binding ligands in the modeling may be helpful.
It should be mentioned that although TASSER generates
high conﬁdence models for a substantial amount of medium/
hard targets, the majority of the high C-score models are
from easy targets. For example, among 749 targets with C-
Figure 3. C-Score Distribution of the Predicted Models for the 907 GPCR Sequences
The C-score histogram for the PDB benchmark proteins [20] is shown for comparison, where dark gray denotes those models with an RMSD less than
6.5 A ˚ to native and the light gray those models whose RMSD greater than 6.5 A ˚. The C-score is defined as in Equation 1. Inset: The cumulative foldable
fraction calculated under the assumption that the GPCR proteins have the same correlation between success and C-score as that of the PDB benchmark
proteins.
DOI: 10.1371/journal.pcbi.0020013.g003
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Structure Modeling of Human GPCRsscore greater than 1.0, 659 are from easy targets. This
correlation indicates that although TASSER has the ability of
structural reﬁnement, the overall success still strongly relies
on the quality of threading templates [34]. Furthermore,
models generated with the explicit membrane potential
showed little difference from those generated with the
integrated form of TASSER (average TM score, 0.91; average
RMSD, 1.8 A ˚ ).
Conformational Changes from the Bovine RH Template
One of the major differences of the current approach from
traditional CM methods is that TASSER reﬁnes the topology
of threading alignments by rearranging the continuous
fragments, while CM builds the model through optimally
satisfying the restraints of the template structures. This
results in the best CM models having the smallest variations
from their initial template. Given the low sequence identity
among GPCRs as a big family, one might expect signiﬁcant
differences from bovine RH, the only template available for
CM methods. Thus, an interesting question is the extent to
which TASSER has changed the conformation with respect to
the initial template. In Figure 4A, we take all targets where
TASSER employed bovine RH as an initial template and when
the ﬁnal model has a C-score greater than 1.3 and calculate
the average distances of the residues of the ﬁnal model from
the corresponding residues in the bovine RH template
according to the PROSPECTOR_3 alignment. On average,
most residues in the TASSER model are greater than 4 A ˚ away
from the threading alignments with the maximum conforma-
tional changes in the loop and tail regions. In Figure 4B, we
also show the helix angle changes of the predicted models
with respect to bovine RH after superposition with TM-align
[35]. Obviously, these conformational changes are signiﬁ-
cantly larger than the inherent resolution of TASSER
modeling—as shown in the green triangles in Figure 4A and
4B; if we model bovine RH using its own crystal structure as
the template, the overall RMSD of the model is 0.49 A ˚ , with
the observed variation along the RH template signiﬁcantly
smaller than the predicted average displacement for the
other GPCR proteins. This degree of conformational change
from the template is higher than could be expected by using a
comparative modeling approach. Based on our previous
benchmark and blind test results [20,21,36,37], most of the
conformational deviations from the templates are in the
correct direction toward native structures. For example,
when starting from threading templates with a 4 to 5 A ˚ RMSD
to native, 58% of targets improve by at least 1 A ˚ ; when
starting from a good threading template with a 2 to 3 A ˚
RMSD to native, 43% of targets have at least a 0.5 A ˚
improvement [20]. Even starting from the best structure
alignments, similar improvements of ﬁnal models relative to
templates have been demonstrated (e.g., starting from initial
structure alignments with an RMSD of 2 to 3 A ˚ , 61% of
targets have at least a 0.5 A ˚ improvement) [36]. These data
give us conﬁdence that the observed deviations from the
bovine RH template are most likely in the direction toward
their native state.
Number of TM Helices
Using an automatic procedure to identify TM helices by
structurally aligning the models to a long helix, we can count
the number of TM helices in the predicted models. Consistent
with the cell membrane thickness, these are typically 17 to 25
residues long [38]. Among the 907 GPCRs, 740 have the seven-
TM helix bundle topology. Ten GPCRs have eight long
helices, where, as visually conﬁrmed, the eighth helix is
located in a tail outside the seven-TM helix bundle. We also
checked by visual inspection all other 157 targets that have
fewer than seven helices. Most have shorter sequence lengths
and a regular TM-like topology. In general, these are
truncated fragments of complete GPCR sequences [39,40].
There are 45 sequences whose global topology is not TM
helix–like. Most have zero- to three-long, non-TM helices.
Sixteen of these are incomplete or alternately spliced
transcripts; most are missing the majority of their TM
regions; three (Q8TDU0, Q8TDV3, Q96HT6) do not appear
to be GPCRs at all based on sequence analysis [41]; two
(Q9HC23 and P06850) are ligands misannotated as GPCRs
[42,43]. The remainder may represent an incorrect TASSER
prediction, since TASSER does not have a trustable C-score
for many of these targets. In fact, only four of these targets
have a C-score greater than 1, including a target misanno-
tated as a GPCR (Q9HC23) and three sequences (Q16503,
Q96HT6, and Q99997) that are fragments of N-terminal
domains and do not include the RH portions of the target
sequence [32].
Structural Clusters of GPCR Models
Although there is little experimental evidence with which
to directly test the validity of TASSER GPCR models, there
exist indirect means of increasing the conﬁdence in our
predictions. First, an extensive membrane benchmark set
from the PDB can be used to verify that TASSER can perform
accurately on similar proteins. Second, we can check the self-
consistency of the models under the assumption that closely
related GPCRs or those with similar ligand speciﬁcities
should in general adopt structures that are most similar to
one another. To examine this, we ﬁrst applied TM-align [35]
to perform all-against-all structural alignments for the core
regions of the predicted GPCR models and clustered the
models based on their structural similarity. The average
pairwise TM-score (a measure of fold consistency that ranges
Figure 4. Conformational Changes of the Predicted TASSER Models from
the Crystal Structure of Bovine RH
Data are the average from those targets where bovine RH is a template
with C-score greater than 1.3 (red diamonds). The green triangles denote
the TASSER model for bovine RH when bovine RH itself is used as the
template (ten missed residues in 1f88 are inserted in the TASSER
modeling). This shows the inherent resolution of the TASSER model.
(A) Average distance of each residue of the TASSER models from the
bovine RH template along the sequence. TM helices are marked in gray.
(B) Percentage of all helices with helix angle changes below the indicated
thresholds.
DOI: 10.1371/journal.pcbi.0020013.g004
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random [44] and that should not be confused with TM
regions) for all 907 targets is 0.71, with an average RMSD of
3.1 A ˚ with over 82% alignment coverage. These data
demonstrate the strong structural conservation of the
characteristic seven-TM helix topology. The conformational
variance arises mainly from differences in TM helix packing
and local helix kinks (Figure 4). Using a high TM score cutoff
of 0.95, 228 GPCRs are clustered into 35 clusters; all other
GPCRs have no structural analogs at this high TM score
cutoff.
In Table 2, we present the top ten cluster results, ranked by
the number of cluster members. There is a very strong
tendency for GPCR function conservation within a given
structure cluster. For example, all 59 members in the ﬁrst
structural cluster are in the olfactory II family according to
their Swiss-Prot assignments [39,40]. There is no olfactory
GPCR in the second cluster; but all 51 members belong to
class A (or putative class A) RH-like GPCRs. In the third
cluster, all ten members are chemokine receptors, a subfamily
of peptide receptors. This demonstrates a consistency of
structures with similar function.
Interestingly, the degree of sequence conservation varies
among the structure clusters. For example, in cluster 7 where
all members are Mas or Mas-related receptors, the average
pairwise sequence identity is 87%. In contrast, in cluster 2,
the average sequence identity is 23%, much lower than the
permissive threshold allowed for robust sequence-based
function inference [45]. In cluster 2, the lowest pairwise
sequence identity, between P04001-P43116, is 13%, but the
models for these two GPCRs have a TM-score of 0.95 and an
RMSD of 1.2 A ˚ over 97.4% of the residues, consistent with the
observation that structure is more conserved than sequence
in evolution [46]. These examples of sequence divergence
with structure convergence also appear in other clusters
(Table 2). It seems suggestive that the global structural
information in the GPCR models may be a useful comple-
ment to sequence-based functional analysis [6].
As an additional means of examining the consistency of the
TASSER models, we examined whether the GPCR subfamily
could be determined based on structure alone. A benchmark
set of GPCR models with a C-score greater than 1.3 that were
part of GPCR subfamilies with similar or identical ligand
speciﬁcities was constructed including adenosine, angioten-
sin, chemokine, endothelial cell differentiation, galanin,
melanocortin, opioid, P2Y nucleotide, prostaglandin, soma-
tostatin, trace amine, and arginine vasopressin subfamilies. In
total, the set consisted of 72 receptors and 12 subfamilies. N-
and C-terminal tails were removed since TASSER tends to
model these regions poorly. Each structure in the set was
compared by TM-align to each other structure in the set. In
75% of the cases, the structure with the highest TM-score
belongs to the correct subfamily (86% of cases have a correct
subfamily member with the four highest scoring structures).
While standard phylogenetic analysis of the peptide sequen-
ces alone would yield correct results (the average sequence
identity between any structure and other members of its
subfamily is 40.5%), this result does indicate a high degree of
consistency amongst the TASSER model structures.
Consistency of Models with Mutagenesis Studies
Although no solved X-ray or NMR structure is available for
human GPCR sequences, numerous afﬁnity labeling and site-
directed mutagenesis experiments have been performed to
identify critical residues and motifs that participate in ligand
binding [2,31,47]. These data provide useful clues about the
spatial contacts of the active site residues by which we can
check to see if our models are consistent. We compared all
TASSER models with C-scores greater than 1.3 to available
mutagenesis studies including complement 5a receptor,
thyroid-releasing hormone receptor, angiotensin receptor 1,
adenosine 3 receptor, chemokine receptors, opioid receptors,
formyl peptide receptor, thromboxane A2 receptor, neuro-
medin B receptor, melatonin 2 receptor, gonadotropin-
releasing hormone receptor, and neuropeptide Y receptors
[48–111]. A subset of these receptors is shown in Figure 5 with
critical residues marked. Excluding N- and C-terminal tails,
we have not found any data that would invalidate our
TASSER models.
Prediction of Ligand Specificity for an Orphan Receptor
While the ligand binding afﬁnities of GPCRs tend to closely
follow the sequence-based phylogenetic placement, there are
Table 2. Top Ten Structural Clusters of GPCR Models
Cluster N
a ,id.
b idm
c ID
d TM/RMSD/Cov
e Function
f
1 59 0.38 0.23 Q9H342-Q8NG82 0.96/1.1 A ˚/0.995 Olfactory II fam 2–8
2 51 0.23 0.13 P04001-P43116 0.95/1.2 A ˚/0.974 Class A nonolfactory
3 10 0.33 0.25 P46092-Q16570 0.97/0.9 A ˚/0.986 Chemokine
4 10 0.34 0.26 Q8NGI0-Q8NGK9 0.96/1.2 A ˚/0.993 Olfactory
5 8 0.46 0.27 O95499-Q9Y5P1 0.95/1.4 A ˚/0.988 Olfactory
6 6 0.38 0.30 Q8NGI1-Q8NH67 0.97/0.9 A ˚/0.990 Olfactory
7 5 0.87 0.79 Q8TDD6-Q96LB2 0.99/0.7 A ˚/0.998 Mas and Mas related
8 5 0.50 0.41 Q8NGP3-Q8NGV6 0.97/1.2 A ˚/0.998 Olfactory
9 5 0.45 0.39 Q8NGK4-Q9Y5P0 0.97/1.0 A ˚/0.997 Olfactory
10 4 0.49 0.40 Q8NGD5-Q8NGL9 0.97/1.1 A ˚/0.996 Olfactory
aNumber of members in the clusters.
bAverage pairwise sequence identity of the GPCRs in the clusters.
cThe minimum pairwise sequence identity of the GPCRs in the clusters.
dSWISS-PROT ID of the GPCRs that have the minimum sequence identity as in column 3.
eTM-score, RMSD, and the structural alignment coverage by TM-align for the predicted models of the GPCR pairs at column 4.
fFunctional descriptions of the GPCR members in the cluster, from the annotation in SWISS-PROT database [40].
DOI: 10.1371/journal.pcbi.0020013.t002
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RDC1 receptor. After being initially identiﬁed, RDC1
remained an orphan receptor for 15 years. While RDC1 does
not have a striking homology to any other GPCR, it appears
to be most closely related to the adrenomedullin receptor
(ADMR) and places consistently with it in phylogenetic
studies [112,113]. However, RDC1 was recently shown to be
a receptor for the chemokine CXCL12, which also binds the
chemokine receptor CXCR4. Pairwise comparison of the
TASSER model for RDC1 to all other 906 GPCR models
without N- and C-terminal tails (which were generated prior
to the discovery that RDC1 binds CXCL12) yields CXCR4 as
the highest TM-score receptor, despite having a lower
sequence identity through the same region. In fact, 63 other
models have a higher TM-score to RDC1 than ADMR, many of
which are other chemokine receptors, suggesting common
structural characteristics that distinguish chemokine and
adrenomedullin receptors. It is important to note that this is
strictly based on a direct structural comparison with no
explicit attention paid to residue identities. Not only does
this provide evidence strengthening the validity of TASSER
models, but it also suggests that these structures may also be
applied toward resolving the ligand speciﬁcities of orphan
receptors as well as toward classiﬁcation of weakly homolo-
gous GPCRs in other species.
Discussion
By incorporating speciﬁc protein-membrane interactions
into the TASSER force ﬁeld, we have extended the TASSER
threading-assembly-reﬁnement methodology [20] and gener-
ated tertiary structure predictions for all 907 registered
GPCRs in the human genome less than 500 amino acids long.
Unlike traditional CM methods, TASSER does not require
that the structures of homologous templates be solved, an
essential attribute for the successful modeling of the whole
set of human GPCR proteins, because most GPCRs have no
close evolutionary relationship to proteins in the PDB.
Moreover, TASSER often reﬁnes the structures closer to
native than the templates on which they are based [20,21].
This is particularly important for understanding the func-
tional subtleties of the different classes of GPCRs when the
models start from similar template alignments. These features
have been demonstrated in the benchmark modeling of 38
representative medium-size membrane proteins from the
PDB library, where TASSER has drawn the initial threading
templates closer to native by an average RMSD of 4.9 A ˚ in the
threading aligned regions. An example of special interest is
from RH of bovine rod outer segment membrane, the only
solved GPCR protein. Excluding homologous proteins of
sequence identity greater than 30% as well as bacteriorho-
dopsin, the threading program PROSPECTOR_3 [14] iden-
tiﬁes three helical templates, all with global RMSD greater
than 10 A ˚ . After TASSER reassembly, the ﬁrst model has a
full-length RMSD to native of 4.6 A ˚ , with the TM helix region
having an RMSD of 2.1 A ˚ . Recently, there have been many
other attempts to model the tertiary structure of bovine RH.
For example, Sale et al. [30] modeled the TM helix region
using a statistical potential combined with 27 experimental
distance constraints. They built a model with an RMSD of 3.2
A ˚ to native in the TM region. Becker and coworkers [27,29]
used PREDICT to model the TM region and generated a
model whose TM region has an RMSD from native of 2.9 A ˚ .
Using MembStruk, Vaidehi et al. [114] built a model with an
RMSD from native of 3.1 A ˚ in the TM region and an RMSD
from native of 8.3 A ˚ for the full-length molecule. Compared
with these results, the TASSER model is more accurate in the
TM helix region, the loop/tail regions, and the full-length
molecule.
Among the models generated for the 907 GPCR sequences,
based on the conﬁdence score established in comprehensive
PDB benchmarking [20,21], 819 GPCRs are anticipated to
have the correct global fold. Seven hundred ﬁfty ORFs have
the characteristic seven-TM helix topology, and 112 ORFs
have the TM helix bundle topology with less than seven TM
helices. There are 45 cases where TASSER generates non-TM
helical models, primarily because these sequences come from
periplasmic domain regions.
A quantitative structural comparison of the models from
different GPCRs was performed by an all-against-all struc-
tural superposition. The average pairwise TM-score of the
Figure 5. Consistency of Mutagenesis Studies with TASSER Predictions
TASSER models for gonadotropin hormone-release receptor, adenosine 3
receptor, mu opioid receptor, and melatonin 2 Receptor are shown with
experimental determined residue interactions highlighted as spheres
(green, ligand binding; yellow, disulfide bond; red, residue-residue
interaction).
DOI: 10.1371/journal.pcbi.0020013.g005
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82% of residues in the core region. Using a restrictive TM-
score cutoff of 0.95, the models tend to be grouped into
structural clusters that have strong functional conservation,
although sequences can be very divergent within the clusters.
This is suggestive that structural information from the
predicted GPCR models can be a useful complement to
sequence-based functional analysis. It also demonstrates the
robustness of TASSER, since structural convergence at low
sequence identity is not built in but is a prediction.
A further validation of the predicted models includes
structural consistency of GPCR subfamilies binding the same
or similar ligands and consistency with mutagenesis studies.
Furthermore, we demonstrate that the GPCR models can be
more sensitive in determining ligand speciﬁcity than
sequence-based methods, as is evidenced by the TASSER
model of RDC1. Using sequence-based methods, RDC1 was
expected to be an adrenomedullin receptor, since it shares its
highest sequence identity and places phylogenetically with
ADMR. However, RDC1 was recently shown to bind the
chemokine CXCL12, whose only other known receptor is
CXCR4. The TASSER model of RDC1 has as its closest
structural neighbor, the model of CXCR4, further supporting
the accuracy of TASSER models.
Comparative modeling approaches are useful in inferring
the structures of sequences with greater than 30% sequence
identity. They are also attractive because the computation
resources required in generating these models are relatively
small. However, 99% of GPCRs have a sequence identity less
than 19.5% to the only solved GPCR structure, bovine RH. It
is clear that comparative modeling alone would be unable to
capture the range of structural diversity encompassed by the
907 receptors examined in this study. Alternatively, receptors
can be modeled using speciﬁc restraints and assumptions that
are assumed to be true for all GPCRs based on the solved
rhodopsin structures at the risk of missing unforeseen
structural characteristics of poorly characterized GPCRs.
Threading using PROSPECTOR_3 along with TASSER has
a demonstrated ability to construct accurate models of both
membrane and globular proteins in a completely automated
fashion with low-homology templates, thus providing an
advantage over both the comparative modeling techniques
and methods geared to strictly modeling GPCRs. While
deﬁnitive validation of these structures is difﬁcult given the
paucity of clearly discriminating experimental evidence—the
very reason why many have looked to predicted models in the
ﬁrst place—our benchmark studies of other membrane
proteins and examination of the GPCR models for consis-
tency with existing observations strongly suggests that these
models are rather accurate.
The models presented here represent the most complete
set of GPCRs models developed to date and offer a resource
for ligand screening and other functional predications
[27,115]. Given the extensive computational time required
to generate these models (several decades, if run on a single
processor), this study makes a resource available for
experimental testing that would be infeasible for most
experimental labs to generate independently. All predicted
GPCR models, as well as follow-up functional analysis data,
are available for noncommercial users on our Web site (http://
www.bioinformatics.buffalo.edu/GPCR).
Materials and Methods
Template identiﬁcation. For a given GPCR sequence, we run the
threading program PROSPECTOR_3 to identify putative related
template structures in the PDB. PROSPECTOR_3 is an iterative
sequence/structure alignment approach [14]. On the basis of the score
signiﬁcance and the consensus of template alignments, proteins are
categorized into easy, medium, and hard targets. These terms refer to
the relative conﬁdence in the accuracy of the predicted threading
models. According to the benchmark, 80% of the threading-predicted
alignments for the easy targets have an RMSD to native less than 6.5 A ˚
in the aligned regions [20]. This alignment accuracy is essentially the
same for both globular and membrane proteins [21]. For the medium/
hard targets, the topology of the template is often correct, but the
global alignment can be in error. Nevertheless, the local fragments
from the template alignment can be utilized as building blocks in
TASSER [20].
Substructure/fragment assembly. Continuous fragments (more
than ﬁve residues) are excised from the ﬁve top scoring threading
templates for the easy targets and up to the 20 top templates for the
medium/hard targets. For the GPCR sequences, these fragments are
mainly long TM helices that will be reassembled under the guide of
the TASSER force ﬁeld that consists of an optimized combination of
a reduced knowledge-based potential [17] and consensus contact
restraints from threading [14]. The loops connecting the helices are
generated by the TASSER ab initio structure prediction procedure.
Conformational space is searched by the parallel hyperbolic Monte
Carlo algorithm [116]. Depending on GPCR length, 40 to 80 replicas
are used with larger molecules having more replicas. Two kinds of
major conformational updates are implemented: Off-lattice move-
ments of the template-excised fragments involve rigid translations
and rotations controlled by the three Euler angles of each fragment.
Lattice-conﬁned loop residues are subject to two to six bond
movements and multibond sequence shifts [17].
Extension of TASSER to membrane proteins. The hydrophobic
interactions in the original TASSER force ﬁeld are applied only to the
loop/tail residues, which are assumed to be outside the membrane.
For the putative TM helices, because of the hydrophobic membrane
environment, a propensity for hydrophilic side chains to face to the
interior of the protein is included. TM helices are assigned from
PSIPRED [117]. We also tried other TM predictors, e.g., MEMSAT
[38], but the differences are small. In general, the local geometry of a
template-derived substructure remains similar to that in the template
[20]. However, considering the variance of helix shape and the
presence of local kinks along the TM helices, we allow a small bending
deformation for the aligned TM helices. A strong penalty potential
term of E ; DRMSD
4 is employed (the form of the fourth power is
somewhat arbitrary but was chosen based on trial and error); DRMSD
denotes the RMSD between the excised template substructure and
the deformed substructure in the simulations.
Model selection and assessment. Trajectories of the 14 lowest
temperature replicas are submitted to SPICKER [37] for structure
clustering. SPICKER ﬁrst identiﬁes a center structure that has the
most neighboring structures within an RMSD threshold Rcut. The ﬁrst
cluster is deﬁned as a group of structures including the center
structure and all its neighbors. The second cluster is similarly deﬁned
after all the structures in the ﬁrst cluster have been removed, etc. Rcut
is deﬁned in an iterative way: The initial Rcut is set to 7.5 A ˚ . If the
structures are too tightly distributed, Rcut will gradually decrease
until the ﬁrst cluster contains less than 70% of the total number of
structures or until Rcut is 3.5 A ˚ . If the structures are too divergent,
Rcut will gradually increase until the ﬁrst cluster includes more than
15% of structures or until Rcut ¼ 12 A ˚ .
To avoid distortions of clusters from disordered tail variations, a
two-step clustering is implemented: We ﬁrst run SPICKER on the
structurally well deﬁned core (the putative TM region based on
PSIPRED) and the tail regions separately; then, we dock the
conformations of the three separate parts (the two tails and the
core) into the ﬁnal full-length model based on the superposition of
these regions onto the structure obtained by clustering the full-length
conformations. Reduced models (Cas and side-chain centers of mass)
are provided from the clustered structures. Backbone and side-chain
heavy atoms are added using PULCHRA [118].
The ﬁnal models are ranked and assessed on the basis of the
conﬁdence score [20]:
C   score ¼ ln
M
hrmsdiMtot
Z

ð1Þ
where M is the multiplicity of structures in a SPICKER cluster, Mtot is
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denotes the average RMSD of the structures relative to the cluster
centroid. The logarithm in Equation 1 serves to expand the range of
the C-score distribution of the predicted structures. If we deﬁne a
correct fold as the one with an RMSD to native below 6.5 A ˚ [119], the
PDB benchmark results [20] show that for all targets with a C-score
threshold of  0.5, the total false positive/false negative rate is 12.4%/
14.7%.
Supporting Information
Accession Numbers
The Swiss-Prot (http://www.ebi.ac.uk/swissprot) accession numbers for
the four sequences of registered human GPCRs that have a sequence
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for the bovine RH crystal structure is 1f88A.
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